Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 714,100 | 818,300 | 930,100 | 718,400 | 653,800 |
| Marketable Securities | 242,400 | 519,200 | 341,000 | 506,300 | 785,000 |
| Receivables | 537,300 | 479,300 | 414,600 | 371,800 | 325,000 |
| Inventories | 607,000 | 554,900 | 396,600 | 339,900 | 296,800 |
| Other current assets | 131,800 | 116,900 | 111,800 | 66,400 | 121,700 |
| TOTAL | $2,286,900 | $2,549,200 | $2,240,000 | $2,047,900 | $2,231,100 |
| Non-Current Assets | |||||
| PPE Net | 867,500 | 679,700 | 580,000 | 482,500 | 442,900 |
| Investments And Advances | 0 | 567,000 | 532,100 | 379,900 | 240,900 |
| Intangibles | 1,455,400 | 1,594,500 | 830,900 | 833,700 | 399,400 |
| Other Non-Current Assets | 713,900 | 276,000 | 327,000 | 312,300 | 208,700 |
| TOTAL | $3,036,800 | $3,117,200 | $2,270,000 | $2,008,400 | $1,291,900 |
| Total Assets | $5,323,700 | $5,666,400 | $4,510,000 | $4,056,300 | $3,523,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 598,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 134,000 | 116,600 | 97,100 | 63,900 | 58,200 |
| Accrued Expenses | 742,600 | 653,700 | 435,400 | 412,300 | 367,900 |
| Other current liabilities | N/A | 51,700 | N/A | N/A | N/A |
| TOTAL | $876,600 | $1,420,000 | $532,500 | $476,200 | $426,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 593,800 | 438,400 | 822,300 | 596,900 | 598,100 |
| Other Non-Current Liabilities | 712,900 | 851,800 | 536,200 | 480,100 | 307,400 |
| TOTAL | $1,306,700 | $1,290,200 | $1,358,500 | $1,077,000 | $905,500 |
| Total Liabilities | $2,183,300 | $2,710,200 | $1,891,000 | $1,553,200 | $1,331,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 623,299 | 630,071 | 637,487 | 643,793 | 647,040 |
| Common Shares | 215,200 | 212,000 | 242,600 | 239,100 | 128,900 |
| Retained earnings | 2,694,700 | 1,962,100 | 3,906,300 | 3,336,800 | 2,841,900 |
| Other shareholders' equity | -138,900 | -132,800 | -198,700 | -182,600 | -100,800 |
| TOTAL | $3,140,400 | $2,956,200 | $2,619,000 | $2,503,100 | $2,191,400 |
| Total Liabilities And Equity | $5,323,700 | $5,666,400 | $4,510,000 | $4,056,300 | $3,523,000 |